as per update on website
11 October 2021
Dear shareholders,
I am very pleased to be able to inform you about our next successful steps in today's update.
After we had to wait at least 1.5 years for our EU_GMP inspection due to the COVID pandemic, we finally
succeeded in September of this year to welcome the German inspectors from Arnsberg in North
Macedonia.
Within ten days, our two production sites were inspected by HAPA pharm in Spancevo / Greenhouse and
RH pharma in Skopje / extraction plant.
The following results were achieved:
1. HAPA pharm in Spancevo complies with the GACP and GMP rules and, after some internal adjustments,
is expected to be registered in the international market this year in the EUDRAG list as an EU GMP
company
2. RH pharma in Skopje, as a pharmaceutical producer of medicinal products and extracts of all kinds,
complies with all necessary EU-GMP rules and is expected to be in place by the end of the year and get a
registration in the international EUDRAG_list.
After a 1.5 year delay, all of the success-relevant goals for the HAPA Group have been achieved, and could
potentially become one of the TOP 10 companies to belong in the cannabis industry worldwide with a
focus on "medical cannabis".
Of course, as a German company, in the first step we will focus on the largest market worldwide for
medical cannabis GERMANY, which is 100% funded by health insurance. Some very constructive
discussions with various large German pharmaceutical companies have already taken place and we are
quite sure that we will finally be able to place our medical cannabis products on the market with great
power by the end of the year.
We are currently planning to import around 500kg of THC cannabis flowers and around 15,000 60ml of
THC / CBD bottles to Germany by the end of the year.
Of course, we will market our flowers and extracts worldwide and, as shareholders, you will receive an
up-to-date inventory of our two production facilities:
We will keep you up to date this year and look forward to informing you about the next successful steps.
Kind Regards,
Ricardo Pendon
DIRECTOR AND CEO
Expand
